Widespread availability of self-administered eSAGE (BrainTest® https://braintest.com) expected to be a major factor in overcoming the many obstacles in identifying early Cognitive impairment LONDON, July 17, 2017 (GLOBE NEWSWIRE) — BrainTest Inc., a medical software company that provides scientifically validated cognitive screening instruments on a wide range of tablets and mobile devices, today announced that that the results of its Validity/Equivalency Study were presented at the Alzheimer’s Association International Conference 2017 (AAIC). Data presented by Dr. Douglas W. Scharre, Professor of Clinical Neurology and Psychiatry at The Ohio State University Wexner Medical Center demonstrates eSAGE performs similarly with neuropsychological batteries, […]